Supha Pharmachem Faces Insolvency Over Rs 7.47 Crore Debt

Insolvency Filing Triggered by Debt The Mumbai bench of the National Company Law Tribunal (NCLT) has started insolvency proceedings against Supha Pharmachem, formerly known as Remedium Lifecare. This decision came after an operational creditor claimed Supha Pharmachem defaulted on Rs 7.47 crore for raw material payments. The tribunal acknowledged the debt, and an interim professional,…

Bankruptcy court admits BSE-listed Supha Pharmachem under Insolvency Resolution Process

The bankruptcy court in Mumbai has admitted the listed pharma firm, Supha Pharmachem (formerly Remedium Lifecare), to the Corporate Insolvency Resolution Process (CIRP) and has appointed Rajesh Jhunjhunwala as the interim resolution professional (IRP) of the company. Mumbai-based Supha Pharmachem’s operational creditor, Boston Ivy Healthcare Solution, had approached the National Company Law Tribunal (NCLT) after…

No Cookies | Daily Telegraph

Please note that by blocking any or all cookies you may not have access to certain features, content or personalization. For more information see our Cookie Policy. To enable cookies, follow the instructions for your browser below. Facebook App: Open links in External Browser There is a specific issue with the Facebook in-app browser intermittently…

Your browser is not supported

Your browser is not supported | tennessean.com tennessean.com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use. Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on…

Access Denied

Access Denied You don’t have permission to access “http://www.business-standard.com/companies/news/better-cash-recovery-and-track-record-kept-adani-ahead-in-jal-race-126032701085_1.html” on this server. Reference #18.8ef23717.1774635867.24f68845 https://errors.edgesuite.net/18.8ef23717.1774635867.24f68845 Read the original article here